Volume 14, Issue 3 (3-2016)                   IJRM 2016, 14(3): 181-186 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farhadifar F, Khodabandehloo M, Ramazanzadeh R, Rouhi S, Ahmadi A, Ghaderi E, et al . Survey on association between Mycoplasma hominis endocervical infection and spontaneous abortion using Polymerase Chain Reaction. IJRM 2016; 14 (3) :181-186
URL: http://ijrm.ir/article-1-734-en.html
1- Social Determinants of Health Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
2- Cellular and Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran
3- Cellular and Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran , microbiol_sci@yahoo.com
4- Department of Genecology, Kurdistan University of Medical Sciences, Sanandaj, Iran
Abstract:   (3229 Views)
Background: Mycoplasma infections are suggested as etiology of adverse pregnancy outcomes.
Objective: The aim of this study was to evaluate the association of Mycoplasma hominis (M. hominis) infection and spontaneous abortion among pregnant women.
Materials and Methods: In this case-control study that was conducted from August 2012 to January 2013, totally, 109 women were included with spontaneous abortion with gestational ages of 10-20 weeks (Cases), and 109 women with normal pregnancy with gestational ages between 20-37 weeks (Controls) in Sanandaj, Iran. Using specific primers and extracted DNA from endocervical swabs, a PCR test was conducted for detection of M. hominis infection in women. For comparison of qualitative and quantitative variables, independent Fisher tests were used and          p<0.05 was considered significant.
Results: The total frequency of M. hominis infection was 6 (2.75%) in women. The frequency of M. hominis infection was 2 (1.83%) in the case group (spontaneous abortion) and 4 (3.66%) in the control group, respectively. In both case and control groups, no association was seen between M.hominis infection and spontaneous abortion (OR=0. 49, CI 95%: 0.08-2.73, p=0. 683).
Conclusion: M. hominis was positive in the genital tract of some pregnant women, but it was not associated with spontaneous abortion. However, to prevent adverse pregnancy outcomes in women, foetus and neonate, routine screening and treatment for the genital Mycoplasma is recommended.
Full-Text [PDF 138 kb]   (798 Downloads) |   |   Full-Text (HTML)  (376 Views)  
Type of Study: Original Article |

References
1. Capoccia R, Greub G, Baud D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Curr Opin Infect Dis 2013; 26: 231-240. [DOI:10.1097/QCO.0b013e328360db58]
2. Nigro G, Mazzocco M, Mattia E, Di Renzo GC, Carta G, Anceschi MM. Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med 2011; 24: 983-989. [DOI:10.3109/14767058.2010.547963]
3. Petit E, Abergel A, Dedet B, Subtil D. The role of infection in preterm birth. J Gynecol Obstet Biol Reprod (Paris) 2012; 41: 14-25. [DOI:10.1016/j.jgyn.2011.10.004]
4. Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard HA, Kock MM. Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women. BMC Infect Dis 2014; 14: 171. [DOI:10.1186/1471-2334-14-171]
5. Kataoka S, Yamada T, Chou K, Nishida R, Morikawa M, Minami M, et al. Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. J Clin Microbiol 2006; 44: 51-55. [DOI:10.1128/JCM.44.1.51-55.2006]
6. Kwak DW, Hwang HS, Kwon JY, Park YW, Kim YH. Co-infection with vaginal Ureaplasma urealyticum and Mycoplasma hominis increases adverse pregnancy outcomes in patients with preterm labor or preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2014; 27: 333-337. [DOI:10.3109/14767058.2013.818124]
7. Choi SJ, Park SD, Jang IH, Uh Y, Lee A. The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. Ann Lab Med 2012; 32: 194-200. [DOI:10.3343/alm.2012.32.3.194]
8. Perni SC, Vardhana S, Korneeva I, Tuttle SL, Paraskevas LR, Chasen ST, et al. Mycoplasma hominis and Ureaplasma urealyticum in midtrimester amniotic fluid: association with amniotic fluid cytokine levels and pregnancy outcome. Am J Obstet Gynecol 2004; 191: 1382-1386. [DOI:10.1016/j.ajog.2004.05.070]
9. Fatholahzadeh B, Bahador A, Haghighi Hasanabad M, Bazarjani F, Haghighi F. Comparative screening of Chlamydia trachomatis infection in women population in Tehran, Iran. Iran Red Crescent Med J 2012; 14: 289-293.
10. Mohagheghi P, Khosravi N, Noorbakhsh S, Shekarabi M, Azad K, Looni T. Ureaplasma Urealyticum and Mycoplasma Hominis Colonization and Chronic Lung Disease in Preterm Neonates Under Ventilation. J Compr Ped 2013; 3: 110-114. [DOI:10.5812/jcp.8192]
11. Bayraktar MR, Ozerol IH, Gucluer N, Celik O. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in pregnant women. Int J Infect Dis 2010; 14: 90-95. [DOI:10.1016/j.ijid.2009.03.020]
12. Govender S, Theron GB, Odendaal HJ, Chalkley LJ. Prevalence of genital mycoplasmas, ureaplasmas and chlamydia in pregnancy. J Obstet Gynaecol 2009; 29: 698-701. [DOI:10.3109/01443610903184033]
13. Najar Peerayeh S, Samimi R. Comparison of culture with the polymerase chain reaction for detection of genital Mycoplasma. Eur J Gen Med 2008; 5: 107-111. [DOI:10.29333/ejgm/82587]
14. Cunningham SA, Mandrekar JN, Rosenblatt JE, Patel R. Rapid PCR detection of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum. Int J Bacteriol 2013; 2013: 1-7. [DOI:10.1155/2013/168742]
15. Patel MA, Nyirjesy P. Role of Mycoplasma and ureaplasma species in female lower genital tract infections. Curr Infect Dis Rep 2010; 12: 417-422. [DOI:10.1007/s11908-010-0136-x]
16. Svenstrup HF, Jensen JS, Bjo¨rnelius E, Lidbrink P, Birkelund S, Christiansen G. Development of a quantitative Real-Time PCR assay for detection of Mycoplasma genitalium. J Clin Microbiol 2005; 43: 3121-3128. [DOI:10.1128/JCM.43.7.3121-3128.2005]
17. Hashemi M, Gholampour Azizi I, Rezai Z, Rouhi S. Mycological survey and total Aflatoxin analyze in silage from the Qaemshahr city (Northern Iran). J Chem Health Risks 2012; 2: 51-56.
18. Baczynska A, Svenstrup HF, Fedder J, Birkelund S, Christiansen G. Development of Real-time PCR for detection of Mycoplasma hominis. BMC Microbiol 2004; 4: 35. [DOI:10.1186/1471-2180-4-35]
19. Rodrigues MM, Fernandes PA, Haddad JP, Paiva MC, Souza Mdo C, Andrade TC, et al. Frequency of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Mycoplasma hominis and Ureaplasma species in cervical samples. J Obstet Gynaecol 2011; 31: 237-241. [DOI:10.3109/01443615.2010.548880]
20. Rezeberga D, Lazdane G, Kroica J, Sokolova L, Donders GG. Placental histological inflammation and reproductive tract infections in a low risk pregnant population in Latvia. Acta Obstet Gynecol Scand 2008; 87: 360-365. [DOI:10.1080/00016340801936487]
21. Donders GG, Van Bulck B, Caudron J, Londers L, Vereecken A, Spitz B. Relationship of bacterial vaginosis and mycoplasmas to the risk of spontaneous abortion. Am J Obstet Gynecol 2000; 183: 431-437. [DOI:10.1067/mob.2000.105738]
22. Kacerovsky M, Pliskova L, Bolehovska R, Skogstrand K, Hougaard DM, Tsiartas P, et al. The impact of the microbial load of genital mycoplasmas and gestational age on the intensity of intraamniotic inflammation. Am J Obstet Gynecol 2012; 206: 342. [DOI:10.1016/j.ajog.2012.01.004]
23. Ryckman KK, Williams SM, Kalinka J. Correlations of selected vaginal cytokine levels with pregnancy-related traits in women with bacterial vaginosis and mycoplasmas. J Reprod Immunol 2008; 78: 172-180. [DOI:10.1016/j.jri.2008.02.001]
24. Mor G, Cardenas I. The Immune System in Pregnancy: A Unique Complexity. Am J Reprod Immunol 2010; 63: 425-433. [DOI:10.1111/j.1600-0897.2010.00836.x]
25. Aydin Y, Atis A, Ocer F, Isenkul R. Association of cervical infection of Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis with peritoneum colonisation in pregnancy. J Obstet Gynaecol 2010; 30: 809-812. [DOI:10.3109/01443615.2010.519063]
26. Baczynska A, Hvid M, Lamy P, Birkelund S, Christiansen G, Fedder J. Prevalence of Mycoplasma genitalium, Mycoplasma hominis and Chlamydia trachomatis among Danish patients requesting abortion. Syst Biol Reprod Med 2008; 54: 127-134. [DOI:10.1080/19396360802042838]
27. Zdrodowska-Stefanow B, Kłosowska WM, Ostaszewska-Puchalska I, Bułhak-Kozioł V, Kotowicz B. Ureaplasma urealyticum and Mycoplasma hominis infection in women with urogenital diseases. Adv Med Sci 2006; 51: 250-253.
28. Capocciaa R, Greubb G, David Bauda D. Ureaplasma urealyticum, Mycoplasma hominis and adverse pregnancy outcomes. Pediatr Neonat Infect 2013; 26: 231-240. [DOI:10.1097/QCO.0b013e328360db58]
29. Yeganeh O, Jeddi-Tehrani M, Yaghmaie F, Kamali K, Heidari-Vala H, Zeraati H, et al. A survey on the prevalence of Chlamydia trachomatis and Mycoplasma genitalium infections in symptomatic and asymptomatic men referring to urology clinic of labbafinejad hospital, Tehran, Iran. Iran Red Crescent Med J 2013; 15: 340-344. [DOI:10.5812/ircmj.8600]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb